29240-45-7

Upstream product

• 57625-74-8 methyl 2-methyl-2-phenylpropionate 
• 2173-69-5 2-methyl-2-phenyl-propan-1-ol 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 1616921-76-6 9-hydroxy-2-isopropyl-6-(2-methyl-2-phenylpropyl)-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,8-dione 
• 1616923-05-7 3-methyl-3-phenylbutanimidamide hydrochloride 
• 1616923-06-8 tert-butyl 5-(benzyloxy)-6-hydroxy-2-(2-methyl-2-phenylpropyl)pyrimidine-4-carboxylate 
• 1616923-07-9 5-(benzyloxy)-6-hydroxy-2-(2-methyl-2-phenylpropyl)pyrimidine-4-carboxylic acid 
• 1616923-08-0 5-(benzyloxy)-N-(2-(tert-butyldimethylsilyloxy)ethyl)-6-hydroxy-N-isopropyl-2-(2-methyl-2-phenylpropyl)pyrimidine-4-carboxamide 
• 1616923-09-1 5-(benzyloxy)-6-hydroxy-N-(2-hydroxyethyl)-N-isopropyl-2-(2-methyl-2-phenylpropyl)pyrimidine-4-carboxamide 
• 1616923-10-4 9-(benzyloxy)-2-isopropyl-6-(2-methyl-2-phenylpropyl)-3,4-dihydro-1H-pyrazino[1,2-c]pyrimidine-1,8(2H)-dione 
• 17684-33-2 β,β-dimethyl-β-phenylpropionitrile 

Relevant academic research and scientific papers

PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE

The present invention relates to a compound having the general formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.